DuPont de Nemours' (DD) planned sale of its Aramids business to Arclin has received clearance from the European Commission, the commission said Friday.
The proposed deal "would not raise competition concerns, given that the companies are not active in the same or vertically related markets," the European Commission said.
In August, DuPont said it agreed to sell Aramids to Arclin in a deal valuing the business at roughly $1.8 billion, with closing expected in Q1.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.